Top Diseases Stories


Comment & Analysis »

GlobalData Healthcare

Novel Hyperkalemia Agents Race Toward the European CKD Market

For more than half a century in Europe, there have been no novel treatments indicated specifically for chronic kidney disease (CKD)-associated hyperkalemia. As such, the arrival of new...

Novel Hyperkalemia Agents Race Toward the European CKD Market
Elly Earls

Osteoporosis breakthrough: positive news in a field plagued by bad press

Osteoporosis breakthrough: positive news in a field plagued by bad press
GlobalData Healthcare

Ten-year old NICE restrictions on Velcade limit patient access to next-gen therapies

Ten-year old NICE restrictions on Velcade limit patient access to next-gen therapies
GlobalData Healthcare

Why has the Industry seen higher numbers of Drug Designations than ever before?

Why has the Industry seen higher numbers of Drug Designations than ever before?
GlobalData Healthcare

ESC Congress Barcelona 2017 Highlights – What is the Role of Monotherapies in the Treatment of PAH Patients?

ESC Congress Barcelona 2017 Highlights – What is the Role of Monotherapies in the Treatment of PAH Patients?

Diseases Insights »

Companies »